The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,036.00
Bid: 12,036.00
Ask: 12,038.00
Change: 12.00 (0.10%)
Spread: 2.00 (0.017%)
Open: 11,950.00
High: 12,066.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: BoE expects strong UK growth in 2nd quarter

Thu, 06th May 2021 12:09

(Alliance News) - Stock prices in London were marginally higher at midday on Thursday in the wake of the Bank of England's latest interest rate decision, while US drugmakers were in focus after the Biden administration backed a plan to waive Covid-19 vaccine patents.

The central bank left the key UK interest rate unchanged at 0.1% and its quantitative easing programme untouched, with the total target stock of asset purchases at GBP895 billion.

The Bank of England said the outlook for the UK economy remains uncertain due to the virus pandemic. It predicted that gross domestic product will increase sharply in the second quarter but for growth slow thereafter as the boost from reopening wanes.

Following the BoE announcement, the pound was quoted at USD1.3902 at midday Thursday, down from USD1.3910 at the London equities close Wednesday.

Just prior to the announcement, FTSE 100 index was up 15.22 points, or 0.2%, at 7,054.52. The mid-cap FTSE 250 index was up 128.35 points, or 0.6%, at 22,514.25. The AIM All-Share index was down 0.6% at 1,254.10.

The Cboe UK 100 index was up 0.1% at 702.20. The Cboe 250 was up 0.7% at 20,205.81, and the Cboe Small Companies up 0.2% at 14,739.26.

In mainland Europe, the CAC 40 in Paris was down 0.1%, while the DAX 30 in Frankfurt was down 0.2%.

On the economic front, UK services sector activity growth hit a seven-and-a-half year high in April as lockdown restrictions eased, according to IHS Markit.

The IHS Markit/CIPS UK services purchasing managers' index was revised higher to 61.0 points in April from a preliminary estimate of 60.1, having registered 56.3 in March.

The latest reading signalled the fastest pace of expansion in the sector since October 2013.

In the FTSE 100, Next was the best performer, up 3.5%, after the high street and online retailer boosted its full-year profit guidance for a second time this year following a strong first quarter.

Next said full price sales were down 1.5% in the 13 weeks to May 1 on two years ago, before the Covid-19 pandemic, which the company said was a more "meaningful" comparison.

The FTSE 100 clothing and homewares retailer said it had assumed full-price sales during period would be down 10%, but beat this forecast by GBP75 million. As such, Next raised its central guidance for full-year pretax profit by GBP20 million to GBP720 million.

In April, the Leicester, England-based firm had raised its central profit guidance by GBP30 million to GBP700 million and "optimistically" ruled out further store closures as the UK's vaccine rollout continued.

Looking ahead, Next said it expects the recent post-lockdown sales surge to be short lived - based on the experience of last year - with sales to settle back toward guidance levels within the next few weeks.

Barratt Developments was up 2.0%. The housebuilder said it has performed well since the start of the calendar year reflecting underlying market strength and strong customer demand for "high-quality sustainable new homes".

For the period from January 1 to this past Sunday, total forward sales were GBP3.7 billion, up 31% from GBP2.83 billion at the same time in 2020, and it delivered 4,481 home completions, up 28% from 3,504.

The increase in completions in the period reflected the delivery of customers' homes in line with the UK government's original Help to Buy scheme and the stamp duty holiday deadlines, Barratt said.

Mexican miner Fresnillo was up 1.3%, tracking spot gold prices higher. The precious metal was quoted at USD1,793.58 an ounce Thursday midday, up from USD1,781.79 late Wednesday.

National Grid was up 1.2% after Berenberg raised the UK power lines operator to Buy from Hold.

Melrose Industries was up 1.0%. The industrial turnaround specialist said that, in the four months to April 30, trading was modestly ahead of expectations.

Melrose said the momentum seen in the second half of 2020 has continued into 2021, with sales in the period being 8% higher than in the same period in 2020. Excluding Nortek Air Management, group sales grew by 4%. Last month, Melrose agreed to sell Nortek Chicago-based Madison Industries for GBP2.62 billion.

Further, Melrose said operating margins achieved in the first quarter of the year continued to improve faster than expected, and cash generation has been encouraging, with Melrose "being cash neutral in the first quarter, in what is traditionally a cash outflow period".

Looking ahead, Melrose said it expects improvements in trading to continue, but noted the growth rate will be hindered by supply issues for semi-conductors in the global automotive supply chain.

At the other end of the large-caps, Mondi was the worst performer, down 4.1%. The packaging firm said it delivered a "robust performance" in the first quarter despite an expected decline in earnings.

Mondi reported underlying earnings before interest, tax, depreciation and amortisation of EUR353 million, down 8.3% from EUR385 million a year ago. This was in line with the company's expectations, however. Ebitda was up 14% from EUR309 million in the fourth quarter of last year.

Admiral Group, Polymetal International and Croda International were among the worst performers, down 3.5%, 3.0% and 2.9% respectively. The stocks went ex-dividend meaning new buyers no longer qualify for the latest payout.

The euro was priced at USD1.2049, up from USD1.2000. Against the yen, the dollar was trading at JPY109.13, down from JPY109.26.

Polling stations were open for voters to cast their ballots in a set of elections which could shake up British politics and have profound implications for the future of the UK.

On what has been dubbed 'Super Thursday', polling stations opened across Great Britain in the largest test of political opinion outside a general election, with the future of the Labour Party and the state of the Union among the issues at play.

Scottish National Party leader Nicola Sturgeon's push for a second independence referendum means the stakes are high in the Holyrood contest.

In England, as well as local council and mayoral contests, the Hartlepool parliamentary by-election will indicate what progress - if any - Labour has made in regaining votes in its former northern heartlands.

"For GBP, the Scottish parliamentary elections are certainly the one that investors will be watching. If the Scottish National Party manage to achieve a majority, the chances of a Scottish independence referendum is high. This result could negatively impact the British currency, as without Scotland, the British economy weakens," said analysts at OFX.

Brent oil was trading at USD68.70 a barrel at midday, down sharply from USD69.89 late Wednesday.

US stock market futures were pointed higher with the latest jobless claims numbers in focus ahead of the nonfarm payrolls report due on Friday.

The Dow Jones Industrial Average was called up 0.1%, the S&P 500 index up 0.1%, and the Nasdaq Composite up 0.3%.

US President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for Covid-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.

US Trade Representative Katherine Tai said that while intellectual property rights for businesses are important, Washington "supports the waiver of those protections for Covid-19 vaccines" in order to end the pandemic.

Tedros Adhanom Ghebreyesus, head of the World Health Organization, called the US decision "historic" and marked "a monumental moment in the fight against Covid-19."

Patents give drugmakers a short-term monopoly on production to cover the high costs of research and development. Biotech firms have argued that these protections provided incentives to produce Covid-19 vaccines in a short period.

Tai in recent weeks has met with executives from all the major US vaccine producers - Pfizer, Moderna and Johnson & Johnson - to discuss the issue.

Pfizer, Moderna, Novavax and J&J shares were down 3.1%, 2.2%, 5.6% and 0.6% respectively in pre-market trade in New York. In London, AstraZeneca was up 0.7% in London, but BioNTech - partner of Pfizer on Covid-19 vaccines - was down 16% in Frankfurt.

The economic events calendar on Thursday has US jobless claims at 1330 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.